Evidence map›Paper›PMID 41296315›Full record

ArticleJournal of managed care & specialty pharmacy2025

Requiring continuous enrollment during follow-up? A call for robust research methods.

Sujith Ramachandran, Joel Farley, John P Bentley

Abstract read
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sujith RamachandranDepartment of Pharmacy Administration, School of Pharmacy, University of Mississippi, University.
Joel FarleyDepartment of Pharmaceutical Care & Health Systems, University of Minnesota, Minneapolis.
John P BentleyCenter for Pharmaceutical Marketing & Management, School of Pharmacy, University of Mississippi, University.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Critical evidence for the evaluation and implementation of managed care strategies relies on researchers examining the health outcomes and costs associated with various pharmacological and nonpharmacological treatments and interventions. These studies usually leverage secondary data sources, such as administrative claims or electronic health records, and it is customary for researchers to design studies that explicitly exclude study participants that may be lost to follow-up. These exclusion criteria can be commonly referred to as continuous enrollment requirements and are ubiquitous in health outcomes research because such criteria are straightforward to implement and justify. However, requiring study participants to be continuously enrolled after the start of follow-up may lead to time-related biases, which can lead to lack of validity in study results. This article illustrates a type of time-related bias known as immortal time bias and explains how requirements for continuous enrollment during follow-up can contribute to this and other time-related biases. We examine the reasons individuals are usually lost to follow-up-death, insurance termination, or switching of insurance-and consider the various mechanisms by which these events can bias study estimates. We then delineate various considerations for evaluating the impact of attrition on various studies and conclude with a brief discussion of methods for avoiding time-related biases. We discuss recommendations for researchers to report useful attrition tables, reevaluate their study designs, and take steps to limit susceptibility to time-related biases. Additionally, resources for redesigning studies vulnerable to bias are presented along with some analytical strategies.

Indexed as

Managed Care ProgramsPatient SelectionResearch DesignBiasElectronic Health RecordsFollow-Up StudiesHumansLost to Follow-UpTime Factors

Identifiers

PMID41296315
PMCPMC12653622

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.